CHAMPIONS ONCOLOGY, INC. Increase (Decrease) in Other Noncurrent Liabilities
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Increase (Decrease) in Other Noncurrent Liabilities of $0 for the 9-month period ending 2023-01-31, per its 10-Q filed 2023-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2023-03-16
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2023-01-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-10-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-07-31 was $0.00, a 100.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-04-30 was -$50.00K.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent liabilities for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent liabilities for fiscal 2021 was $3.00K, a 88.89% decline from fiscal 2020.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent liabilities for fiscal 2020 was $27.00K.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in other noncurrent liabilities for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2023-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $0.00 10-Q · filed 2023-03-16 | -$50.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2022-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-13 | $0.00 10-Q · filed 2022-12-13 | -$50.00K derived: sum of 3 quarters · filed 2022-12-13 | -$54.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2022-07-31 | $0.00 10-Q · filed 2022-09-12 | -$50.00K derived: sum of 2 quarters · filed 2022-09-12 | -$54.00K derived: sum of 3 quarters · filed 2023-03-16 | -$62.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2022-04-30 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | -$54.00K derived: sum of 2 quarters · filed 2023-03-16 | -$62.00K derived: sum of 3 quarters · filed 2023-03-16 | $0.00 10-K · filed 2022-07-22 |
| 2022-01-31 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-16 | -$12.00K derived: sum of 2 quarters · filed 2023-03-16 | $50.00K 10-Q · filed 2023-03-16 | $50.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-10-31 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-13 | $54.00K 10-Q · filed 2022-12-13 | $54.00K derived: sum of 3 quarters · filed 2022-12-13 | $54.00K derived: sum of 4 quarters · filed 2022-12-13 |
| 2021-07-31 | $62.00K 10-Q · filed 2022-09-12 | $62.00K derived: sum of 2 quarters · filed 2022-09-12 | $62.00K derived: sum of 3 quarters · filed 2022-09-12 | $64.00K derived: sum of 4 quarters · filed 2022-09-12 |
| 2021-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | $0.00 derived: sum of 2 quarters · filed 2022-07-22 | $2.00K derived: sum of 3 quarters · filed 2022-07-22 | $3.00K 10-K · filed 2022-07-22 |
| 2021-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-15 | $2.00K derived: sum of 2 quarters · filed 2022-03-15 | $3.00K 10-Q · filed 2022-03-15 | $30.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-10-31 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-13 | $3.00K 10-Q · filed 2021-12-13 | $30.00K derived: sum of 3 quarters · filed 2021-12-13 | $30.00K derived: sum of 4 quarters · filed 2021-12-13 |
| 2020-07-31 | $1.00K 10-Q · filed 2021-09-13 | $28.00K derived: sum of 2 quarters · filed 2021-09-13 | $28.00K derived: sum of 3 quarters · filed 2021-09-13 | $28.00K derived: sum of 4 quarters · filed 2021-09-13 |
| 2020-04-30 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26 | $27.00K derived: sum of 2 quarters · filed 2021-07-26 | $27.00K derived: sum of 3 quarters · filed 2021-07-26 | $27.00K 10-K · filed 2021-07-26 |
| 2020-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-15 | $0.00 derived: sum of 2 quarters · filed 2021-03-15 | $0.00 10-Q · filed 2021-03-15 | |
| 2019-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-14 | $0.00 10-Q · filed 2020-12-14 | ||
| 2019-07-31 | $0.00 10-Q · filed 2020-09-14 | |||
| 2019-04-30 | $0.00 10-K · filed 2020-07-28 | |||
| 2018-04-30 | -$272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29 | -$121.00K derived: sum of 2 quarters · filed 2019-07-29 | $30.00K derived: sum of 3 quarters · filed 2019-07-29 | $30.00K 10-K · filed 2019-07-29 |
| 2018-01-31 | $151.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | $302.00K derived: sum of 2 quarters · filed 2018-03-19 | $302.00K 10-Q · filed 2018-03-19 | $238.00K derived: sum of 4 quarters · filed 2018-07-30 |
| 2017-10-31 | $151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-15 | $151.00K 10-Q · filed 2017-12-15 | $87.00K derived: sum of 3 quarters · filed 2018-07-30 | $87.00K derived: sum of 4 quarters · filed 2018-07-30 |
| 2017-07-31 | $0.00 10-Q · filed 2017-09-14 | -$64.00K derived: sum of 2 quarters · filed 2018-07-30 | -$64.00K derived: sum of 3 quarters · filed 2018-07-30 | -$64.00K derived: sum of 4 quarters · filed 2018-07-30 |
| 2017-04-30 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30 | -$64.00K derived: sum of 2 quarters · filed 2018-07-30 | -$64.00K derived: sum of 3 quarters · filed 2018-07-30 | -$44.00K 10-K · filed 2018-07-30 |
| 2017-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | $0.00 derived: sum of 2 quarters · filed 2018-03-19 | $20.00K 10-Q · filed 2018-03-19 | $21.00K derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-15 | $20.00K 10-Q · filed 2017-12-15 | $21.00K derived: sum of 3 quarters · filed 2017-12-15 | $50.00K derived: sum of 4 quarters · filed 2017-12-15 |
| 2016-07-31 | $20.00K 10-Q · filed 2017-09-14 | $21.00K derived: sum of 2 quarters · filed 2017-09-14 | $50.00K derived: sum of 3 quarters · filed 2017-09-14 | $85.00K derived: sum of 4 quarters · filed 2017-09-14 |
| 2016-04-30 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $30.00K derived: sum of 2 quarters · filed 2017-07-28 | $65.00K derived: sum of 3 quarters · filed 2017-07-28 | $65.00K 10-K · filed 2017-07-28 |
| 2016-01-31 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-17 | $64.00K derived: sum of 2 quarters · filed 2017-03-17 | $64.00K 10-Q · filed 2017-03-17 | $164.00K derived: sum of 4 quarters · filed 2017-03-17 |
| 2015-10-31 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-14 | $35.00K 10-Q · filed 2016-12-14 | $135.00K derived: sum of 3 quarters · filed 2016-12-14 | $135.00K derived: sum of 4 quarters · filed 2016-12-14 |
| 2015-07-31 | $0.00 10-Q · filed 2016-09-14 | $100.00K derived: sum of 2 quarters · filed 2016-09-14 | $100.00K derived: sum of 3 quarters · filed 2016-09-14 | |
| 2015-04-30 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $100.00K derived: sum of 2 quarters · filed 2016-07-29 | $100.00K 10-K · filed 2016-07-29 | |
| 2015-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-16 | $0.00 10-Q · filed 2016-03-16 | ||
| 2014-10-31 | $0.00 10-Q · filed 2015-12-15 | |||
| 2014-04-30 | $0.00 10-K · filed 2015-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |